VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

• Status: WITHDRAWN
• Trial end date: 2024-08-14

Summary

This study will assess safety, tolerability and pharmacokinetic (PK) of VH3739937 in healthy participants.

• Phase: PHASE1

Details

• Lead Sponsor: ViiV Healthcare